Summary of product characteristics humira








Humira Pre-filled Pen, Pre-filled Syringe and Vial - Summary of

9/17/2014
01:18 | Author: Jeremy Rodriguez

Summary of product characteristics medicine
Humira Pre-filled Pen, Pre-filled Syringe and Vial - Summary of

Humira Pre-filled Pen, Pre-filled Syringe and Vial - Summary of Product Characteristics (SPC) by Abbvie Limited.

There is no relevant use of Humira in the paediatric population in the indications, ankylosing spondylitis and psoriatric arthritis. Method of administration.

Humira is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who failed to respond to or who have a contraindication to, or are intolerant to other systemic therapy including cyclosporine, methotrexate or PUVA. Crohn's disease.

Humira therapy should not be continued in patients failing to respond within this time period.

Comments (1)Read more



European Medicines Agency - Find medicine - Humira

7/16/2014
03:04 | Author: Chloe Allen

Summary of product characteristics medicine
European Medicines Agency - Find medicine - Humira

6 days ago What is Humira used for? Humira is How has Humira been studied?. More detail is available in the summary of product characteristics.

Humira has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate. Juvenile idiopathic arthritis.

The European Commission granted a marketing authorisation valid throughout the European Union for Humira on 8 September 2003.

Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Humira, including the appropriate precautions to be followed by healthcare professionals and patients.

Comments (2)Read more

Humira - Search Results - Evidence Search - Search Engine for

5/15/2014
05:06 | Author: Allison King

Summary of product characteristics medicine
Humira - Search Results - Evidence Search - Search Engine for

Results 1 - 10 IN Advanced search > SPC Logo Humira Pre-filled Pen, Pre-filled Syringerelated medicine report side effect Humira 40 mg solution for injection in.

US Food and Drug Administration, 16 June 2009 Read Summary.

All Wales Medicines Strategy Group, 14 August 2013 Read Summary.

...Antimicrobial Prescribing Group You are here: Home > SMC Advice > Advice > adalimumab ( Humira ) > adalimumab_ Humira adalimumab ( Humira ) Advice following an abbreviated submission adalimumab ( Humira ) solution for injection.

electronic Medicines Compendium, 10 September 2014 - Publisher: electronic Medicines Compendium (eMC), Datapharm Communications Ltd - Publication type: Summary of Product Characteristics.

Your has been sent.

.immune response Cytokine modulators ADALIMUMAB Share Linked In Twitter Facebook More.

Comments (3)Read more

HUMIRA (adalimumab) Official Site from AbbVie Inc

3/14/2014
07:12 | Author: Chloe Allen

Summary of product characteristics medicine
HUMIRA (adalimumab) Official Site from AbbVie Inc

Official site containing product information, news and resources. Abbott Laboratories.

Moderate to Severe Ulcerative Colitis (UC).

Registered nurses can help you learn to inject.

*Available Monday through Friday from 8 AM to 8 PM ET. At other times, nurses will return calls within 1 hour.

Our trained nurses can schedule a time to visit your home, doctor’s office, or clinic to provide injection training for HUMIRA.

Sign Up for Insights & Updates on UC and HUMIRA.

Please see the Full Prescribing Information, including the Medication Guide, for HUMIRA.

How HUMIRA Works to Treat Plaque Ps.

Registered nurses are on call to answer questions you may have about HUMIRA around the clock.*

Ankylosing Spondylitis (AS).

Comments (4)Read more

Anti-tumour Necrosis Factor Alpha (anti-TNF-alpha) Doctor Patient

1/13/2014
09:50 | Author: Jeremy Rodriguez

Summary of product characteristics medicine
Anti-tumour Necrosis Factor Alpha (anti-TNF-alpha) Doctor Patient

Summary of Product Characteristics (SPC) - Humira (adalimumab); Summary of Summary of Product Characteristics (SPC) - Remicade 100 mg powder for.

Cautions include: Contra-indications include:. The trials have been done according to manufacturers' dosage schedules and can vary according to age and indication.

is one of the most trusted medical resources online, supplying evidence based information on a wide range of medical and health topics to patients and health professionals.

TNF-alpha is an inflammatory cytokine or pro-inflammatory mediator which, when present in excessive concentrations, is responsible for the destructive inflammatory processes that occur in, for example, articular cartilage and bone in RA.

Comments (5)Read more